Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trayodashang Guggulu is a traditional Ayurvedic polyherbal formulation primarily used for the management of musculoskeletal and neurological disorders, including sciatica, paralysis, and osteoarthritis. The name "Trayodashang" refers to its thirteen primary herbal ingredients, which are combined with Guggulu (Commiphora mukul) resin. It is recognized for its anti-inflammatory, analgesic, and anti-arthritic properties. In clinical research, such as the HEAL-KOA trial conducted by the All India Institute of Medical Sciences, Jodhpur, it is being evaluated as part of an integrated or standalone Ayurvedic care regimen for early knee osteoarthritis to reduce pain and improve joint function. The formulation is believed to work by balancing the 'Vata' dosha and inhibiting pro-inflammatory mediators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trayodashang guggulu.